Gene Query: PTPRU

Dataset Description Geneva Score
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 89.62
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 72.45
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 65.76
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 63.63
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 47.4
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 43.31
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 41.76
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 39.68
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 37.72
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 37.51
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 35.93
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 35.66
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 35.48
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 34.97
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 33.17
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 33.17
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 32.97
RNA-seq analysis of BAP1-depleted uveal melanoma cells 32.69
Generation of trichogenic adipose-derived stem cells by expression of three factors 32.65
Entrectinib Resistance in a Neuroblastoma Xenograft Model 32.54
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 32.49
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 32.41
H1609088 Human RNA-Sequencing 31.85
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 31.36
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 30.81
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 30.38
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 30.23
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 30.22
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 30.22
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 29.29
IRF2 is a master regulator of human keratinocyte stem cell fate 29.29
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 29.16
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 29.03
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 29.02
Depicting early human development and germ cell origin with porcine embryos 28.01
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 27.95
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 27.44
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 26.61
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 26.21
DART-seq: an antibody-free method for global m6A detection 26.15
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 26.06
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 25.87
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 24.37
CHCHD2 gene KO effect in iPSC drived motor neurons 23.8
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 23.54
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 23.51
HNF1 regulates critical functions of the human epididymis epithelium. 23.51
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 23.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 23.27
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 23.23
PGE2 mediated gene expression changes in human cervical stromal cells 22.99
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 22.89
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 22.8
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 22.8
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 22.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 22.68
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 22.68
RNA-seq of human aneuploid cell lines with Trisomy 21 22.48
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 22.29
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 22.18
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 21.93
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 21.75
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 21.72
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 21.68
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 21.5
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 21.13
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 21.07
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 20.47
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 20.39
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 20.38
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 20.38
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 20.28
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 20.28
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 20.26
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 20.25
Role of CD133 molecule in WNT response and renal repair 19.94
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 19.81
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 19.62
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 19.28
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 19.17
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 19.08
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 19.08
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 18.99
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 18.99
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 18.99
Targeting EZH2 in MYCN-amplified Neuroblastoma 18.8
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 18.8
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 18.5
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 18.49
RNA-seq of MCF10A cells and CAF 18.45
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 18.44
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 18.31
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 18.17
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 18.01
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 17.95
Silencing p300 in MCF7 cells to study expression and alternative splicing 17.86
Identifying the molecular mode of action of itraconazole in colorectal cancer 17.77
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 17.74
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 17.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 17.39
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 17.39
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 17.34
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 17.13
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 17.12
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 16.98
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 16.98
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 16.81
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 16.74
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 16.74
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 16.47
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 16.41
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 16.35
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 16.32
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 16.12
The cohesin complex prevents Myc-induced replication stress 16.11
Oncogenic MYC induces a dependency on the spliceosome in human cancer 16.09
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 16.06
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 15.91
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 15.89
AMPK signaling for naïve pluripotency 15.88
AMPK signaling for naïve pluripotency [Hs] 15.88
MRTF activates TEAD-YAP target gene expression 15.81
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 15.77
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 15.77
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 15.58
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 15.48
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 15.44
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 15.36
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.33
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 15.14
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 15.12
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 15.09
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 15.0
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 14.99
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 14.77
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 14.74
CHCHD10 gene KO effect in iPSC drived motor neurons 14.72
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 14.68
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 14.5
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 14.42
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 14.36
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 14.36
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 14.25
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.22
Global transcriptome analysis of HAP1 cells 14.11
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 14.07
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 14.0
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 13.97
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 13.94
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 13.9
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 13.86
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 13.83
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.7
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.7
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 13.68
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 13.66
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 13.66
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 13.64
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 13.62
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.57
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 13.51
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 13.41
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 13.41
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 13.36
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 13.28
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 13.28
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 13.14
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 13.13
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 13.13
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 12.85
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 12.83
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 12.74
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 12.63
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 12.59
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 12.58
SETBP1-WT and SETBP1-G870S epigenetic landscapes 12.54
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 12.54
Transcriptome analyses of human pancreatic islets and pseudoislets 12.54
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 12.53
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 12.48
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 12.47
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 12.38
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 12.38
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.31
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 12.3
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 12.28
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 12.19
Gene expression changes in human melanoma cell lines compared to primary melanocytes 12.14
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 12.11
NHLRC1 re-expression in cancer cells 12.1
ARID1A regulates condensin II distribution and chromosomal partition 12.09
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 12.09
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 12.07
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 12.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 11.99
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 11.99
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 11.98
Differetially expressed genes after hTR overexpression in U2OS cells 11.91
Transcriptomic analysis of the HOTAIR-regulated genes 11.74
Overexpression and knockdown experiment for circCSNK1G3 11.71
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 11.7
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 11.67
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 11.66
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 11.61
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 11.43
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 11.42
LIN28A modulates splicing and gene expression programs in breast cancer cells 11.27
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 11.27
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 11.18
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 11.13
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 11.13
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 11.09
Transcriptomic and gene ontology profiling of the human corneal cell types 11.08
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 11.03
RNA-seq of YB5 cells treated with Proscillaridin A 11.0
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.97
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 10.97
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.95
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.88
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 10.86
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.86
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 10.78
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 10.78
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 10.76
ARID1A and ARID1B loss in HCT116 cells 10.75
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 10.71
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 10.71
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 10.69
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 10.64
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 10.64
Genome wide expression change by RNF168 knocking down in NEC cells 10.63
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 10.61
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 10.6
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 10.58
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 10.5
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 10.5
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 10.5
WRN knockout effects upon gene expression in SW48 and OVK18 10.47
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.42
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 10.28
RNA sequencing of human mammary epithelial cells 10.28
Gene expression profiling of human and murine in vitro muscle differentiation 10.24
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 10.23
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 10.19
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 10.12
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.12
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 10.12
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 10.12
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 10.11
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 10.11
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 10.1
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 10.02
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.01
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.01
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.99
RNA transcriptome analysis during HSV-1 infection 9.91
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 9.89
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.78
RNA Sequencing of three pairs of gastric cancer 9.74
Ribosomal protein RPL26 is the principal target of UFMylation 9.72
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 9.72
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.7
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.64
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.63
RNA-seq of shEZH2 cells 9.58
Transcriptome analysis upon C6orf203 silencing 9.56
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 9.54
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 9.54
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 9.48
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 9.48
Paxillin regulates genomic networks in prostate cancer [C4-2] 9.47
A transcriptome dataset revealing the molecular features of breast cancer stem cells 9.46
RNA-seq of naive and primed ES cells 9.45
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 9.32
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 9.3
Tyrosine Kinase Inhibitor Cardiotoxicity 9.26
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 9.26
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 9.24
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 9.23
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 9.15
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.14
Non-coding regions are the main source of tumor-specific antigens 9.05
Non-coding regions are the main source of tumor-specific antigens [human] 9.05
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 8.88
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 8.86
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 8.81
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 8.79
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 8.78
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 8.78
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 8.72
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.71
RNA-seq differential expression studies: more sequence, or more replication? 8.7
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 8.54
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.44
Differential gene expression profiles in imatinib-resistant cell lines 8.28
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 8.25
A transcriptome-wide divergence in protein translation scales with LIN28B expression 8.25
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 8.12
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 8.12
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 8.1
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 8.07
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 8.06
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 8.05
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.91
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 7.89
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 7.89
The DNA methylation landscape of human melanoma [RNA-Seq] 7.86
The DNA methylation landscape of human melanoma 7.86
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.79
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.79
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.72
Proteomics identifies a marker signature of MAPKi resistance in melanoma 7.57
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.46
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.42
circNFIB suppresses lymphatic metastasis of pancreatic cancer 7.38
Dissecting neural differentiation regulatory networks through epigenetic footprinting 7.35
CSL 7.34
CSL RNA-Seq on HKC and SCC cell lines 7.34
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 7.26
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 7.25
Generation of KRAS signatures using immortalized isogenic lung cells. 7.25
An siRNA screen identifies CHD4 as a target for epigenetic therapy 7.01
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.97
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.93
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.93
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.85
Androgen Receptor-regulated genes in prostate cancer cells 6.84
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 6.84
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 6.8
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 6.8
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 6.8
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 6.8
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.75
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 6.73
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 6.72
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 6.67
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.66
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.66
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.54
Gene expression profile in breast cancer cell lines using RNA sequencing 6.54
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 6.41
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 6.26
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.15
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.15
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 6.07
Comparative Analysis of Cas9 Activators Across Multiple Species 6.02
Reprogrammed myeloid cell transcriptomes in NSCLC 5.96
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 5.93
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 5.91
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 5.85
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 5.85
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 5.85
Profiling of escape kinetics of viruses subjected to RNAi 5.67
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 5.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 5.6
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 5.6
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 5.51
BMS-470539 on human synovial fibroblasts 5.48
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.33
Expression profiling of MCF-7 cells with treatment of TCDD 5.21
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.21
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 5.19
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.16
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.16
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 4.95
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.91
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.89
Genome-wide transcriptional response to random aneuploidy in human cells 4.86
Ectoderm specification of H1 human embryonic stem cells 4.85
RNA-Sequencing of HepG2 cells treated with TGFBeta 4.83
The cohesin release factor WAPL restricts chromatin loop extension. 4.82
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.82
Molecular Criteria for Defining the Naive Human Pluripotent State 4.68
RNA-seq of SCLC PDX models treated with EP 4.66
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.51
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.47
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 4.43
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.39
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 4.34
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.31
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 4.22
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.17
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 4.16
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.15
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.13
Gene expression analysis upon mtDNA depletion 4.13
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.99
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 3.93
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.92
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.92
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.84
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.81
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.78
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 3.75
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.74
Transcriptome of EBV-infected gastric cancer cell lines 3.52
Effect of nuclear IL-33 on gene expression 3.49
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.44
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.43
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.32
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 3.32
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.31
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.26
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.14
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.1
Identification of long noncoding RNAs regulated by p53 3.09
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.09
The DPYSL2 gene connects mTOR and schizophrenia 3.07
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.03
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 3.03
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.95
Expression profiling of converted and control dermal BJ fibroblasts 2.95
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.95
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.91
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.9
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.9
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.69
Gene expression of thyroid cancer cell lines 2.63
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.63
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.6
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.58
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 2.53
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 2.46
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.46
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.44
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.38
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 2.37
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.35
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.33
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.29
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.25
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.23
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.23
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.09
RNAseq analysis of ruxolitinib treated breast cancers 2.07
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.02
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.02
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.02
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.97
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.91
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.84
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.83
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.83
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 1.78
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.78
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.78
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.65
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.62
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.62
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.59
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.55
Downregulation of DDX5/DDX17 and REST 1.5
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.5
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.46
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.46
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.44
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.44
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.39
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.38
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.25
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.21
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.18
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.14
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 1.13
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 1.13
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.08
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.04
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.04
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.99
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.97
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.96
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 0.89
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 0.89
STX4 Over-Expression in Human islets 0.86
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.77
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.68
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.62
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.62
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.59
HEK293 TFAM Knockout Expression Study 0.56
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.51
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.44
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.44
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.43
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.42
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.39
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.39
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.37
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.27
RNAseq of Breast cancer PDX samples 0.21
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.19
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.19
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.17
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.16
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.15
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.08
RNAseq of T-ALL upon long non coding rna purturbation 0.07
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation